Company intelligence / Profile preview

Cervos Medical

Ownership: Private
Development stage: Commercial

Overview

Cervos Medical develops and markets FDA-cleared devices for harvesting and processing autologous tissues, including a novel Platelet-Rich Plasma (PRP) system. Their products have achieved significant market penetration and regulatory approval, with peer-reviewed journal publications supporting their efficacy.

Therapeutic areas: NeurologyRheumatology
Modalities: Autologous OrthobiologicsRegenerative Medicine
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Cervos Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cervos Medical.

Explore the full profile